Loading the security overview…
Where the tokens are
| Quarter | EPS | EPS vs year ago | Revenue | Revenue vs year ago |
|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | −$3.32 | — | $164.20M | +108.8% |
| Q1 FY26ended Mar 31, 2026 | −$1.06 | −185.5% | $115.24M | +44.9% |
| Q4 FY25ended Dec 31, 2025 | $0.70 | — | $79.76M | −16.0% |
| Q3 FY25ended Sep 30, 2025 | −$0.45 | — | $81.10M | −14.9% |
| Q2 FY25ended Jun 30, 2025 | −$0.04 | — | $78.63M | −44.3% |
| Q1 FY25ended Mar 31, 2025 | $1.24 | +59.0% | $79.53M | −55.6% |
| Q4 FY24ended Dec 31, 2024 | −$0.78 | — | $94.93M | −33.1% |
| Q3 FY24ended Sep 30, 2024 | −$1.17 | — | $95.35M | −15.5% |
| Q2 FY24ended Jun 30, 2024 | −$5.05 | — | $141.10M | — |
| Q1 FY24ended Mar 31, 2024 | $0.78 | — | $179.29M |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss.
Figures describe Core Scientific shares, not any token. From Massive's standardised financials and the earnings calendar.
| — |
| Q4 FY23ended Dec 31, 2023 | −$0.51 | — | $141.93M | — |
| Q3 FY23ended Sep 30, 2023 | −$0.11 | — | $112.90M | — |